Lupus Therapeutics

Lupus Therapeutics At Lupus Therapeutics, we're on a mission to accelerate drug discovery and diagnostic innovation for all patients living with lupus.

06/15/2023

Lupus Therapeutics, an affiliate of Lupus Research Alliance, recently held its second annual Lupus Clinical Investigators Network (LuCIN) Community Meeting.

The highly successful meeting brought together dozens of clinical investigators from our premier LuCIN trials network, study coordinators, people with lupus, research and industry partners for networking, collaboration, and engagement. Key panel discussions spotlighted the future of cell therapies, improving recruitment in clinical trials, and catalyzing treatment development with the multi-faceted nature of lupus.

Watch highlights!

We’re pleased to share that Stacie J. Bell, PhD has been appointed Executive Vice President of Lupus Therapeutics (LT), ...
01/18/2023

We’re pleased to share that Stacie J. Bell, PhD has been appointed Executive Vice President of Lupus Therapeutics (LT), LRA’s affiliate organization formed to advance lupus clinical research by finding more effective and safer treatments for people living with lupus.

“I am excited about working with the lupus community to bring together diverse stakeholders, drive patient engagement, and accelerate clinical research for this disease which requires many individualized treatments. I am honored to further the mission of Lupus Therapeutics.”

Read more about Stacie J. Bell: bit.ly/SJB-LT

Address

New York, NY

Alerts

Be the first to know and let us send you an email when Lupus Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share